Rogier Schepers
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- Cancer Cells and Metastasis 2
-
- Psychosomatic Disorders and Their Treatments 4
- Co-authors
- Eugène Vandermeersch (2 shared papers)Noor Berends (2 shared papers)M. Van de Velde (2 shared papers)Frederik De Buck (2 shared papers)KP Van de Woestijne (3 shared papers)Kris Stegen (3 shared papers)Omer Van den Bergh (3 shared papers)E. Roets (2 shared papers)
- Journals
- European Respiratory Journal (3 papers)Journal of Psychosomatic Research (2 papers)Nature Communications (1 paper)Cell Reports Medicine (1 paper)Cell Reports (1 paper)
- Partner nations
- BelgiumNetherlandsChina
In The Last Decade
Rogier Schepers
22 papers receiving 995 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 157
- Oncology 168
- Neurology 91
- Immunology 108
- Analytical Chemistry 62
Countries citing papers authored by Rogier Schepers
This map shows the geographic impact of Rogier Schepers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogier Schepers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogier Schepers more than expected).
Fields of papers citing papers by Rogier Schepers
This network shows the impact of papers produced by Rogier Schepers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogier Schepers. The network helps show where Rogier Schepers may publish in the future.
Co-authors
The 25 scholars most cited alongside Rogier Schepers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 257 | |
| 2 | 2008 | 141 | |
| 3 | 2024 | 78 | |
| 4 | 1997 | 65 | |
| 5 | 1996 | 64 | |
| 6 | 2023 | 61 | |
| 7 | 1996 | 60 | |
| 8 | 2022 | 53 | |
| 9 | 1998 | 43 | |
| 10 | 2022 | 35 | |
| 11 | 2024 | 29 | |
| 12 | 2000 | 28 | |
| 13 | 2024 | 25 | |
| 14 | 2020 | 24 | |
| 15 | 1997 | 22 | |
| 16 | 2024 | 18 | |
| 17 | 2024 | 15 | |
| 18 | 1999 | 11 | |
| 19 | 2025 | 6 | |
| 20 | 2024 | 2 |
About Rogier Schepers
Rogier Schepers is a scholar working on Oncology, Psychiatry and Mental health, Analytical Chemistry, Infectious Diseases and Immunology, having authored 23 papers that have together received 1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Psychosomatic Disorders and Their Treatments (4 papers), Analytical Methods in Pharmaceuticals (2 papers), Anesthesia and Pain Management (2 papers), COVID-19 Clinical Research Studies (2 papers), Cancer Cells and Metastasis (2 papers), Antifungal resistance and susceptibility (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Infectious Diseases (157 citations), Oncology (168 citations), Neurology (91 citations), Immunology (108 citations) and Analytical Chemistry (62 citations). Rogier Schepers has collaborated with scholars based in Belgium, Netherlands and China. Frequent co-authors include Eugène Vandermeersch, Noor Berends, M. Van de Velde, Frederik De Buck, KP Van de Woestijne, Kris Stegen, Omer Van den Bergh, E. Roets, Erwin Adams and Jos Hoogmartens. Their work appears in journals such as European Respiratory Journal, Journal of Psychosomatic Research, Nature Communications, Cell Reports Medicine and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.